US Broker Ratings

Haemonetics Corporation (HAE) Stock Analysis: Evaluating 37.90% Potential Upside in Medical Device Innovator

Haemonetics Corporation (NYSE: HAE), a key player in the healthcare sector, specifically within the medical devices industry, presents an intriguing investment opportunity for forward-thinking investors. Headquartered..

ACADIA Pharmaceuticals Inc. (ACAD): Investor Outlook with a Promising 21.40% Upside Potential

ACADIA Pharmaceuticals Inc. (ACAD) has captured the attention of investors within the biotechnology sector, a subfield of healthcare that remains a hotbed for innovation. With a..

TransMedics Group, Inc. (TMDX) Stock Analysis: Exploring Growth Potential with 48.2% Revenue Surge

TransMedics Group, Inc. (NASDAQ: TMDX) has been making significant strides in the healthcare sector, particularly within the medical devices industry. As a commercial-stage medical technology company,..

Soleno Therapeutics (SLNO) Stock Analysis: 44% Upside Potential Piques Investor Interest

Investors looking for promising opportunities in the healthcare sector may find Soleno Therapeutics, Inc. (NASDAQ: SLNO) an intriguing prospect. With a market capitalization of $3.87 billion,..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Exploring the 137% Potential Upside for Investors

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a prominent player in the biotechnology sector specializing in RNA-targeted therapeutics and gene therapies, is drawing significant attention from investors. With..

Waystar Holding Corp. (WAY) Stock Analysis: 24.76% Upside Potential and Strong Buy Consensus

Waystar Holding Corp. (NASDAQ: WAY) is garnering significant attention from investors as it positions itself as a prominent player in the healthcare technology sector. With a..

Elanco Animal Health (ELAN) Stock Analysis: Navigating the Path with a 14.89% Upside Potential

Elanco Animal Health Incorporated (NYSE: ELAN), a key player in the healthcare sector, stands out in the Drug Manufacturers – Specialty & Generic industry with its..

Verona Pharma plc (VRNA) Stock Analysis: A Biotech Powerhouse with 25% Upside Potential

Verona Pharma plc (NASDAQ: VRNA), a leading player in the biotechnology sector, is capturing significant attention from investors with its promising pipeline aimed at addressing unmet..

Grifols, S.A. (GRFS) Investor Outlook: Exploring a 33.60% Potential Upside Amidst Healthcare Innovations

Grifols, S.A. (NASDAQ: GRFS), a prominent player in the healthcare sector, is drawing attention from investors with a promising 33.60% potential upside based on current analyst..

Krystal Biotech, Inc. (KRYS) Investor Outlook: Analyzing a 64% Upside Potential in Biotech Innovation

Krystal Biotech, Inc. (NASDAQ: KRYS), a pioneering player in the biotechnology sector, has been capturing investor attention with its promising genetic medicine pipeline and substantial market..

Bruker Corporation (BRKR) Stock Analysis: Exploring a 55% Potential Upside in the Healthcare Sector

Bruker Corporation (BRKR), a prominent player in the healthcare sector, is attracting attention from investors with its noteworthy potential upside of 55.30%. Specializing in medical devices,..

HealthEquity, Inc. (HQY) Stock Analysis: A 13.62% Upside Potential Beckons Investors

HealthEquity, Inc. (NASDAQ: HQY), a prominent player in the healthcare sector, has piqued investor interest with its promise of a potential 13.62% upside. As a leader..

Oscar Health, Inc. (OSCR) Stock Analysis: Unveiling a 37% Potential Upside with Strong Revenue Growth

Oscar Health, Inc. (NYSE: OSCR) is making waves in the healthcare sector with its innovative approach to health plans and technology. As a key player in..

Walgreens Boots Alliance, Inc. (WBA): Investor Outlook Focuses on High Dividend Yield and Strategic Positioning in Healthcare

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) stands as a prominent player in the healthcare sector, operating an expansive network of retail pharmacies both in the United..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Exploring a Potential 118% Upside in Biotech Innovation

Avidity Biosciences, Inc. (NASDAQ: RNA) is capturing the attention of investors with its innovative approach to RNA therapeutics, leveraging its proprietary antibody oligonucleotide conjugates (AOCs) platform...

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Unveiling a 75% Potential Upside with Strong Buy Ratings

Lantheus Holdings, Inc. (LNTH), a prominent player in the healthcare sector specializing in diagnostic and therapeutic products, has captured the attention of the investment community with..

Viatris Inc. (VTRS) Stock Analysis: Navigating a 39.98% Potential Upside Amidst Volatility

Viatris Inc. (NASDAQ: VTRS), a major player in the healthcare sector, stands at a pivotal juncture, drawing significant attention from investors due to its substantial potential..

Bausch + Lomb (BLCO) Stock Analysis: Eyeing a 32.86% Upside Potential

Bausch + Lomb Corporation (NYSE: BLCO), a well-established name in the healthcare sector, is positioned as a significant player within the medical instruments and supplies industry...

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: A Deep Dive into Its 74.47% Potential Upside

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a leader in the biotechnology sector, presents a compelling opportunity for investors looking to delve into the healthcare space. With a..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Unpacking a 15.79% Potential Upside

Smith & Nephew SNATS, Inc. (SNN) stands as a prominent player in the healthcare sector, specializing in medical devices. With a market capitalization of $12.53 billion,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds